Imaging-Based Prediction of Molecular Therapy Targets in NSCLC by Radiogenomics and AI Approaches: A Systematic Review

Imaging-Based Prediction of Molecular Therapy Targets in NSCLC by Radiogenomics and AI Approaches: A Systematic Review

The objective of this systematic review was to analyze the current state of the art of imaging-derived biomarkers predictive of genetic alterations and immunotherapy targets in lung cancer. We included original research studies reporting the development and validation of imaging feature-based models...

Full description

Bibliographic Details
Main Authors:	Gaia Ninatti, Margarita Kirienko, Emanuele Neri, Martina Sollini, Arturo Chiti
Format:	Article
Language:	English
Published:	MDPI AG 2020-05-01
Series:	Diagnostics
Subjects:	radiogenomics CT PET/CT lung cancer EGFR ALK
Online Access:	https://www.mdpi.com/2075-4418/10/6/359

Similar Items

An Explainable Radiogenomic Framework to Predict Mutational Status of KRAS and EGFR in Lung Adenocarcinoma Patients
by: Berardino Prencipe, et al.
Published: (2023-06-01)

Radiogenomics, Breast Cancer Diagnosis and Characterization: Current Status and Future Directions
by: Francesca Gallivanone, et al.
Published: (2022-10-01)

Radiomics and radiogenomics in intrahepatic cholangiocarcinoma
by: A. D. Smirnova, et al.
Published: (2024-03-01)

Clinical Challenge of Two Competing Targetable Mutations in Non-Small-Cell Lung Cancer: A Case Report
by: Sonya Youngju Park, et al.
Published: (2023-10-01)

PET/CT Based EGFR Mutation Status Classification of NSCLC Using Deep Learning Features and Radiomics Features
by: Weicheng Huang, et al.
Published: (2022-04-01)

Predicting MYCN amplification in paediatric neuroblastoma: development and validation of a 18F-FDG PET/CT-based radiomics signature
by: Luo-Dan Qian, et al.
Published: (2023-11-01)

F-18 FDG PET/CT characterization and predictive efficacy for driver mutation positive and negative pulmonary adenocarcinoma in correlation with clinico-pathologic data
by: Ashish Acharya K, et al.
Published: (2023-04-01)

Radiolabeled EGFR TKI as predictive imaging biomarkers in NSCLC patients – an overview
by: Eveline Van De Stadt, et al.
Published: (2022-10-01)

Establishment and Optimization of Radiomics Algorithms for Prediction of KRAS Gene Mutation by Integration of NSCLC Gene Mutation Mutual Exclusion Information
by: Jingyi Wang, et al.
Published: (2022-04-01)

Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict PET Image Quality of Three Generations EGFR TKI in Advanced-Stage NSCLC Patients
by: I. H. Bartelink, et al.
Published: (2022-06-01)

Current Status and Progress in Molecular Imaging of Non-small Cell Lung  Cancer for Molecular Targeted EGFR-TKI Treatment Sensitivity and  Treatment Tolerance Prediction
by: Dong DAI, et al.
Published: (2017-12-01)

Central nervous system involvement of systemic ALK-positive histiocytosis with KIF5B-ALK fusion
by: Yuzuna Aoki, MD, et al.
Published: (2022-10-01)

Quantification of [18F]afatinib using PET/CT in NSCLC patients: a feasibility study
by: E. A. van de Stadt, et al.
Published: (2020-08-01)

Asymptomatic versus symptomatic patients: [18F]FDG-PET/CT patterns and evolutionary track of COVID-19 associated vasculitis
by: Martina Sollini, et al.
Published: (2021-02-01)

Research Progress of Proteolysis Targeting Chimeria in NSCLC Therapy
by: Lin JIANG, et al.
Published: (2022-07-01)

Preoperative Diagnosis and Molecular Characterization of Gliomas With Liquid Biopsy and Radiogenomics
by: Carmen Balana, et al.
Published: (2022-05-01)

Recent and current advances in PET/CT imaging in the field of predicting epidermal growth factor receptor mutations in non-small cell lung cancer
by: Na Hu, et al.
Published: (2022-10-01)

Advances in radiogenomics in precision radiotherapy
by: YE Fei, YU Ying
Published: (2020-05-01)

A review of AI-based radiogenomics in neurodegenerative disease
by: Huanjing Liu, et al.
Published: (2025-02-01)

Correlation between EGFR mutation status and F18‐fluorodeoxyglucose positron emission tomography‐computed tomography image features in lung adenocarcinoma
by: Lei Zhu, et al.
Published: (2019-04-01)

PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs
by: Liping Yang, et al.
Published: (2022-06-01)

ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance
by: Malinda Itchins, BMedSci, M.B.B.S., FRACP, PhD, et al.
Published: (2024-09-01)

Radiogenomics and Radiomics in Liver Cancers
by: Aman Saini, et al.
Published: (2018-12-01)

Potential Therapeutic Strategy for EGFR-Mutant Lung Cancer With Concomitant EML4-ALK Rearrangement—Combination of EGFR Tyrosine Kinase Inhibitors and ALK Inhibitors
by: Ming-Hung Huang, PhD, et al.
Published: (2022-11-01)

Dynamic monitoring of circulating tumor DNA to analyze genetic characteristics and resistance profile of lorlatinib in ALK positive previously treated NSCLC
by: Xiya Ma, et al.
Published: (2023-07-01)

Radiogenomics and machine learning predict oncogenic signaling pathways in glioblastoma
by: Abdul Basit Ahanger, et al.
Published: (2025-01-01)

RadGenNets: Deep learning-based radiogenomics model for gene mutation prediction in lung cancer
by: Satvik Tripathi, et al.
Published: (2022-01-01)

Opportunities and Advances in Radiomics and Radiogenomics for Pediatric Medulloblastoma Tumors
by: Marwa Ismail, et al.
Published: (2023-08-01)

Radiogenomic profiling of global DNA methylation associated with molecular phenotypes and immune features in glioma
by: Zhuokai Zhuang, et al.
Published: (2024-09-01)

Radiogenomics: bridging the gap between imaging and genomics for precision oncology
by: Wenle He, et al.
Published: (2024-09-01)

Radiomics and Radiogenomics in Pelvic Oncology: Current Applications and Future Directions
by: Niall J. O’Sullivan, et al.
Published: (2023-05-01)

The role of artificial intelligence based on PET/CT radiomics in NSCLC: Disease management, opportunities, and challenges
by: Qiuyuan Hu, et al.
Published: (2023-03-01)

Lung Cancer Staging: Imaging and Potential Pitfalls
by: Lauren T. Erasmus, et al.
Published: (2023-11-01)

The complementary role of PSMA expression and [18F]FDG PET/CT in predicting thyroid cancer outcome: from black and white to shades of gray, in the era of precision oncology
by: Martina Sollini, et al.
Published: (2023-06-01)

Radiogenomic analysis of cellular tumor-stroma heterogeneity as a prognostic predictor in breast cancer
by: Ming Fan, et al.
Published: (2023-11-01)

Contrast-Enhanced Computed Tomography–Based Radiogenomics Analysis for Predicting Prognosis in Gastric Cancer
by: Han Liu, et al.
Published: (2022-06-01)

Artificial intelligence-based MRI radiomics and radiogenomics in glioma
by: Haiqing Fan, et al.
Published: (2024-03-01)

Case Report: ALK-Positive Histiocytosis With KIF5B-ALK Fusion in Cerebrum-Disseminated Lesions in a Child
by: Yi Guo, et al.
Published: (2022-03-01)

Methodological framework for radiomics applications in Hodgkin’s lymphoma
by: Martina Sollini, et al.
Published: (2020-06-01)

Development of a PET/CT molecular radiomics-clinical model to predict thoracic lymph node metastasis of invasive lung adenocarcinoma ≤ 3 cm in diameter
by: Cheng Chang, et al.
Published: (2022-04-01)